AstraZeneca PLC (LON:AZN) posted better-than-expected core income in the fourth quarter, thanks to strong demand for its cancer and rare disease therapies that helped make up for waning sales of its COVID-19 vaccine. Core earnings per share during the three months ended on December 31 was $1.38, a drop in actual terms of 17% compared […]
UBS has no interest in buying fellow Swiss lender Credit Suisse, the bank's Chairman Colm Kelleher said in a interview Read more
Goldman Sachs (NYSE:GS), BNP Paribas (OTC:BNPQY), Uncredited (BIT:CRDI) and RBC Capital Markets had earlier expected the ECB’s terminal rate to Read more
Earlier this week, the company announced a $3 billion investment over three years in its Data & AI practice. The Read more
Toyota shareholders backed the board and voted down the first resolution proposed in 18 years at an annual general meeting Read more
UBS has no interest in buying fellow Swiss lender Credit Suisse, the bank’s Chairman Colm Kelleher said in a interview published on Saturday. The former Morgan Stanley (NYSE:MS) president said he was focused on organic growth rather than acquisitions and expanding its business in the United States as he ruled out any move to buy […]
AstraZeneca PLC (LON:AZN) posted better-than-expected core income in the fourth quarter, thanks to strong demand for its cancer and rare Read more
The Annual Duty Division in India charges no assessment on pay acquired through specific means. Notwithstanding, it relies upon different Read more
U.S. stock futures were trading in a tight range during Monday’s evening deals, after major benchmark averages finished the regular Read more
Taiwan's exports in January likely fell for the fifth month in a row amid fears of a global recession, uncertainties Read more
